Reservoir targeted vaccine against borrelia burgdorferi: A new strategy to prevent lyme disease transmission

93Citations
Citations of this article
129Readers
Mendeley users who have this article in their library.

Abstract

A high prevalence of infection with Borrelia burgdorferi in ixodid ticks is correlated with a high incidence of Lyme disease. The transmission of B. burgdorferi to humans can be disrupted by targeting 2 key elements in its enzootic cycle: the reservoir host and the tick vector. In a prospective 5-year field trial, we show that oral vaccination of wild white-footed mice resulted in outer surface protein A-specific seropositivity that led to reductions of 23% and 76% in the nymphal infection prevalence in a cumulative, time-dependent manner (2 and 5 years, respectively), whereas the proportion of infected ticks recovered from control plots varied randomly over time. Significant decreases in tick infection prevalence were observed within 3 years of vaccine deployment. Implementation of such a long-term public health measure could substantially reduce the risk of human exposure to Lyme disease. © 2014 The Author 2014.

Cite

CITATION STYLE

APA

Richer, L. M., Brisson, D., Melo, R., Ostfeld, R. S., Zeidner, N., & Gomes-Solecki, M. (2014). Reservoir targeted vaccine against borrelia burgdorferi: A new strategy to prevent lyme disease transmission. Journal of Infectious Diseases, 209(12), 1972–1980. https://doi.org/10.1093/infdis/jiu005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free